Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Is there a standard adjuvant treatment for colon cancer?M L Slevin, D Papamichael, P Rougier, et al.
Cancer Treatment Reports|December 1, 1987
Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancerS T Malik, H Rayner, J Fletcher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
The efficiency of protective gloves used in the handling of cytotoxic drugsM L Slevin, L M Ang, A Johnston, et al.
Human Toxicology|November 1, 1985
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidoneR J Osborne, M L Slevin, R W Hunter, et al.
Journal of Chromatography|May 3, 1985
High-performance liquid chromatography of etoposide in plasma and urineV J Harvey, S P Joel, A Johnston, et al.
British Journal of Cancer|October 1, 1990
Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volumeW M Gregory, R H Reznek, M Hallett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Predicting etoposide toxicity: relationship to organ function and protein bindingS P Joel, R Shah, P I Clark, et al.
Postgraduate Medical Journal|November 1, 1981
The 'tumour overkill syndrome'. A potentially lethal complication of cancer chemotherapyM L Slevin, R Bell, A M Cotterill, et al.
Lancet (London, England)|August 17, 1985
Cardiotoxicity of intravenous domperidoneR J Osborne, M L Slevin, R W Hunter, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1987
TNO6 in non small cell lung cancerR J Osborne, M L Slevin, P F Wrigley, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Is there a standard adjuvant treatment for colon cancer?M L Slevin, D Papamichael, P Rougier, et al.
Cancer Treatment Reports|December 1, 1987
Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancerS T Malik, H Rayner, J Fletcher, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
The efficiency of protective gloves used in the handling of cytotoxic drugsM L Slevin, L M Ang, A Johnston, et al.
Human Toxicology|November 1, 1985
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidoneR J Osborne, M L Slevin, R W Hunter, et al.
Journal of Chromatography|May 3, 1985
High-performance liquid chromatography of etoposide in plasma and urineV J Harvey, S P Joel, A Johnston, et al.
British Journal of Cancer|October 1, 1990
Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volumeW M Gregory, R H Reznek, M Hallett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Predicting etoposide toxicity: relationship to organ function and protein bindingS P Joel, R Shah, P I Clark, et al.
Postgraduate Medical Journal|November 1, 1981
The 'tumour overkill syndrome'. A potentially lethal complication of cancer chemotherapyM L Slevin, R Bell, A M Cotterill, et al.
Lancet (London, England)|August 17, 1985
Cardiotoxicity of intravenous domperidoneR J Osborne, M L Slevin, R W Hunter, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1987
TNO6 in non small cell lung cancerR J Osborne, M L Slevin, P F Wrigley, et al.
Pageof 14